Global Wearable Injectors Market Size and Forecast 2023-2032| Amgen Inc., Becton Dickinson and Company (BD), Enable Injections LLC, Insulet Corporation, Ypsomed Holding AG,

The Wearable Injectors Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2011-2022) and extends its insights into a ten-year forecast period (2024-2033).

Learn More On The Wearable Injectors Market:

https://www.thebusinessresearchcompany.com/report/wearable-injectors-global-market-report

According to The Business Research Company’s Wearable Injectors Global Market Report 2024, The wearable injectors market size has grown rapidly in recent years. It will grow from $8.04 billion in 2023 to $9.07 billion in 2024 at a compound annual growth rate (CAGR) of 12.9%.  The  growth in the historic period can be attributed to chronic disease management, patient convenience, technological advancements, aging population.

The wearable injectors market size is expected to see rapid growth in the next few years. It will grow to $15.23 billion in 2028 at a compound annual growth rate (CAGR) of 13.8%.  The growth in the forecast period can be attributed to personalized medicine, remote patient monitoring, drug development, chronic disease management. Major trends in the forecast period include biologics and large molecules, dual-chamber wearables, connected and smart devices, patch pump technology.

The rise in the number of diabetic and chronic diseases patients such as cardiovascular diseases and cancers contributed to the growth of the wearable injectors market. According to the International Diabetes Federation, in 2021, approximately 537 million adults were living with diabetes, and by 2045, it is estimated that around 783 million adults around the world and 1 in 5 adults who are above 65 are expected to suffer from diabetes. The rise in the number of diabetes and chronic diseases patients increased the demand for the treatment of the diseases, thereby driving the wearable injectors market growth.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=3308&type=smp

The wearable injectors market covered in this report is segmented –

1) By Type: On-Body Injectors; Off-Body Injectors

2) By End-User: Hospitals; Clinics; Homecare setting

3) By Application: Immuno-Oncology; Diabetes; Cardiovascular Diseases; Other Applications

The wearable injectors market report table of contents includes:

1. Executive Summary

2. Wearable Injectors Market Characteristics

3. Wearable Injectors Market Trends And Strategies

4. Wearable Injectors Market – Macro Economic Scenario

5. Global Wearable Injectors Market Size and Growth

.

.

.

26. South America Wearable Injectors Market

27. Brazil Wearable Injectors Market

28. Middle East Wearable Injectors Market

29. Africa Wearable Injectors Market

30. Wearable Injectors Market Competitive Landscape And Company Profiles

Top Major Players:

• Amgen Inc
• Becton Dickinson and Company
• Enable Injections LLC
• Insulet Corporation
• Ypsomed Holding AG

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model